These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 25731717)

  • 1. Aptamer nanomedicine for cancer therapeutics: barriers and potential for translation.
    Lao YH; Phua KK; Leong KW
    ACS Nano; 2015 Mar; 9(3):2235-54. PubMed ID: 25731717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleic acid aptamer-mediated drug delivery for targeted cancer therapy.
    Zhu H; Li J; Zhang XB; Ye M; Tan W
    ChemMedChem; 2015 Jan; 10(1):39-45. PubMed ID: 25277749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The application of aptamers in cancer research: an up-to-date review.
    Hu M; Zhang K
    Future Oncol; 2013 Mar; 9(3):369-76. PubMed ID: 23469972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aptamers and their applications in nanomedicine.
    Sun H; Zu Y
    Small; 2015 May; 11(20):2352-64. PubMed ID: 25677591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.
    Pangburn TO; Petersen MA; Waybrant B; Adil MM; Kokkoli E
    J Biomech Eng; 2009 Jul; 131(7):074005. PubMed ID: 19655996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances of aptamer-based clinical applications for the diagnosis and therapy of cancer.
    Zhong Y; Wu P; He J; Zhong L; Zhao Y
    Discov Med; 2020; 29(158):169-180. PubMed ID: 33007192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent progresses in biomedical applications of aptamer-functionalized systems.
    Ding F; Gao Y; He X
    Bioorg Med Chem Lett; 2017 Sep; 27(18):4256-4269. PubMed ID: 28803753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid Tumors.
    Xiang D; Zheng C; Zhou SF; Qiao S; Tran PH; Pu C; Li Y; Kong L; Kouzani AZ; Lin J; Liu K; Li L; Shigdar S; Duan W
    Theranostics; 2015; 5(10):1083-97. PubMed ID: 26199647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer nanomedicine: from drug delivery to imaging.
    Chow EK; Ho D
    Sci Transl Med; 2013 Dec; 5(216):216rv4. PubMed ID: 24353161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle-aptamer conjugates for cancer cell targeting and detection.
    Estévez MC; Huang YF; Kang H; O'Donoghue MB; Bamrungsap S; Yan J; Chen X; Tan W
    Methods Mol Biol; 2010; 624():235-48. PubMed ID: 20217600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.
    Namiki Y; Fuchigami T; Tada N; Kawamura R; Matsunuma S; Kitamoto Y; Nakagawa M
    Acc Chem Res; 2011 Oct; 44(10):1080-93. PubMed ID: 21786832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Status and Prospects of Aptamers as Drug Components.
    Mattice CM; DeRosa MC
    BioDrugs; 2015 Jun; 29(3):151-65. PubMed ID: 25985746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aptamer-modified nanoparticles and their use in cancer diagnostics and treatment.
    Reinemann C; Strehlitz B
    Swiss Med Wkly; 2014 Jan; 144():w13908. PubMed ID: 24395443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted drug delivery vehicles mediated by nanocarriers and aptamers for posterior eye disease therapeutics: barriers, recent advances and potential opportunities.
    Zhang T; Jin X; Zhang N; Jiao X; Ma Y; Liu R; Liu B; Li Z
    Nanotechnology; 2022 Jan; 33(16):. PubMed ID: 34965522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aptamers as drug delivery vehicles.
    Kruspe S; Mittelberger F; Szameit K; Hahn U
    ChemMedChem; 2014 Sep; 9(9):1998-2011. PubMed ID: 25130604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Application of functional quantum dots in cancer diagnosis and therapy: a review].
    Han S; Xia T; Li Q; Guo J; Lu P
    Sheng Wu Gong Cheng Xue Bao; 2013 Jan; 29(1):10-20. PubMed ID: 23631114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Selection, Modification and Development of Therapeutic Oligonucleotide Aptamers.
    Yu Y; Liang C; Lv Q; Li D; Xu X; Liu B; Lu A; Zhang G
    Int J Mol Sci; 2016 Mar; 17(3):358. PubMed ID: 26978355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development and testing of aptamers for cancer.
    Barbas AS; White RR
    Curr Opin Investig Drugs; 2009 Jun; 10(6):572-8. PubMed ID: 19513946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy.
    Li X; Zhao Q; Qiu L
    J Control Release; 2013 Oct; 171(2):152-62. PubMed ID: 23777885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA nanomedicine: Engineering DNA as a polymer for therapeutic and diagnostic applications.
    Campolongo MJ; Tan SJ; Xu J; Luo D
    Adv Drug Deliv Rev; 2010 Apr; 62(6):606-16. PubMed ID: 20338202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.